Enrico Martin

265 Morbidity and function loss after resection of MPNST Table 4 Continued. Case Sex, age YOD NF1 Size Tumor site Treatment stage Interval (days)* Reconstructions Other treatment Motor outcome Sensory outcome Clinical outcome F-U (months) 12 F, 60 2010 S 2.1cm C5-6 Initial treatment 13 Ulnar to brachialis nerve, median to biceps to branch neoRTx NA NA DOD 22 13 F, 36 2010 NF1 10.0cm Posterior cord Initial treatment 159 PT to ECRB, FDS IV to EPL, FDS III to EDC IV/V, FCR to APL adRTx Finger extension M3, Wrist extension M2 No recovery M, DOD 76 14 M, 57 2007 S 5.0cm Deltoid muscle Recurrence NA Pedicled LD None Shoulder abduction M0 No recovery LR, M, DOD 61 15 M, 22 2006 NF1 5.5cm Sciatic nerve Initial treatment 0 Gracilis to semitendinosus adRTx Knee flexion M3 No recovery ANOD 135 16 M, 49 2006 S NA MCN Initial treatment 0 Sural nerve graft adCTx Elbow flexion M0 No recovery ANOD 137 17 M, 73 2006 S 4.3cm Tibial bone Initial treatment 0 Tendon allograft for patella None Amputation NA ANOD 53 18 F, 4 2005 S 6.1cm Brachial plexus Initial treatment 0 Nerve grafting**: C5 to SSN, C6 to MCN, C6 and C7 to median nerve neoCTx Shoulder abduction M4,elbow flexion M4, wrist flexion M4, finger and thumb flexion M2-3 NA LR, M, DOD 41 19 F, 31 2001 S 7.0cm Lateral cord Initial treatment NA Nerve graft and nerve transfer neoRTx Amelioration of function NA DOD 25 20 F, 59 2000 S 1.8cm Parotid gland Recurrence NA PL graft in FRFF for mouth corner anchorage adRTx Amelioration in rest NA LR, ANOD 239 21 F, 37 2000 S 7.5cm Median nerve Initial treatment 513 ECRB to FPL, EIP to APB, partial FDP IV/V to FDP II/III ILP, adRTx All hand function M4-5 No recovery ANOD 200 22 F, 44 1998 S 7.5cm Median nerve Initial treatment 0 Sural nerve grafts adRTx Complete median nerve palsy No recovery LR, DOD 35 11